Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
The American Journal of Cardiology
|
September 25, 1999
Trends in the post-hospitalization medical treatment of unstable angina pectoris: 1990 to 1995
N L Smith, G E Reiber, B M Psaty, et al.
Journal of the American College of Cardiology
|
November 11, 1998
Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina
N L Smith, G E Reiber, B M Psaty, et al.
American Heart Journal
|
October 2, 2001
Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics
A Manhapra, J G Canto, H V Barron, et al.
Journal of the American College of Cardiology
|
August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation
N R Every, C P Cannon, C Granger, et al.
The New England Journal of Medicine
|
August 19, 1993
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators
N R Every, E B Larson, P E Litwin, et al.
American Heart Journal
|
September 29, 1999
Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators
A Y Fung, G Lorch, P A Cambier, et al.
Lancet (London, England)
|
July 6, 2000
Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial
W D Weaver, M A Reisman, J J Griffin, et al.
The New England Journal of Medicine
|
May 29, 2000
The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators
J G Canto, N R Every, D J Magid, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
Journal of the American College of Cardiology
|
November 18, 2000
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)
W B Gibler, J W Hoekstra, W D Weaver, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
The American Journal of Cardiology
|
September 25, 1999
Trends in the post-hospitalization medical treatment of unstable angina pectoris: 1990 to 1995
N L Smith, G E Reiber, B M Psaty, et al.
Journal of the American College of Cardiology
|
November 11, 1998
Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina
N L Smith, G E Reiber, B M Psaty, et al.
American Heart Journal
|
October 2, 2001
Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics
A Manhapra, J G Canto, H V Barron, et al.
Journal of the American College of Cardiology
|
August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation
N R Every, C P Cannon, C Granger, et al.
The New England Journal of Medicine
|
August 19, 1993
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators
N R Every, E B Larson, P E Litwin, et al.
American Heart Journal
|
September 29, 1999
Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators
A Y Fung, G Lorch, P A Cambier, et al.
Lancet (London, England)
|
July 6, 2000
Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial
W D Weaver, M A Reisman, J J Griffin, et al.
The New England Journal of Medicine
|
May 29, 2000
The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators
J G Canto, N R Every, D J Magid, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
Journal of the American College of Cardiology
|
November 18, 2000
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)
W B Gibler, J W Hoekstra, W D Weaver, et al.
Page
of 7